Drilldown: Medicines
Appearance
Medicines > routes:
Intravenous (continuous infusion in a REMS-certified facility)
& onset
:
Rheumatologic effect at 4-8 weeks; ectopic resolution over 2-3 weeks
or
None 
& onset
:
Rheumatologic effect at 4-8 weeks; ectopic resolution over 2-3 weeks
or
None 
Use the filters below to narrow your results.
There are no results for this report.

